DYN — DYNE THERAPEUTICS INC

Ownership history in PRUDENTIAL FINANCIAL INC  ·  6 quarters on record

This page tracks every 13F SEC filing in which PRUDENTIAL FINANCIAL INC reported a position in DYNE THERAPEUTICS INC (DYN). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.01% (2024 Q2)
Avg. % of fund
0.01%
First filed
2024 Q1
Last filed
2025 Q3
Quarters held
6
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 ADDED 13,210 +1,505 +12.9% 0.00% $167K $12.65
2025 Q2 REDUCED 11,705 -133,805 -92.0% 0.00% $111K $9.52
2024 Q4 REDUCED 145,510 -110,400 -43.1% 0.00% $3.4M $23.56
2024 Q3 ADDED 255,910 +2,865 +1.1% 0.01% $9.2M $35.92
2 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    DYN price (monthly, adj. close)

Other funds also holding DYN

As of 2025 Q4 — sorted by position size

Atlas Venture Life Science Advisors, LLC 3Y 20.64% FCPM III SERVICES B.V. 14.01% Saturn V Capital Management LP 3Y 6.42% Palo Alto Investors LP 3Y 7Y 4.01% Vivo Capital, LLC 3Y 7Y 3.31% MPM BioImpact LLC 3Y 3.15% TCG Crossover Management, LLC 3Y 2.99% STEMPOINT CAPITAL LP 2.8% VR Adviser, LLC 3Y 2.1% Siren, L.L.C. 2.04%
← Back to PRUDENTIAL FINANCIAL INC Holdings